lilly cares tirzepatide Eli gets nod to launch weight-loss drug in Hong Kong - Bloomberg News FDA approves tirzepatide, Eli Lilly's

Martin earned his MD from Michigan State University and completed his Family Medicine residency at the University of California, Irvine

For a deeper look at that mechanism, see how GLP-1 actually works for weight loss

This can be especially relevant for drugs like semaglutide and tirzepatide, originally diabetes drugs that quickly became mainstream when the FDA granted them approval as weight loss drugs

time to maximum observed INR response

Pregnant or breastfeeding women should also not take semaglutide due to unknown risks it may pose on the growing fetus

A Foundation for Lasting Habits These injections are not a magic wand